mifepristone has been researched along with Complications, Pregnancy in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Bai, M; Chen, M; Jiang, H; Li, P; Lin, N; Lu, S; Ma, Z; Sun, D; Zeng, Q; Zeng, S; Zheng, C; Zhou, H | 1 |
Du, X; Duan, J; Huang, YM; Wang, Y; Yang, Y | 1 |
Mihalceanu, E; Onofriescu, M; Pintilie, R; Pristavu, A; Socolov, D; Vinturache, A | 1 |
Bi, RY; Gan, YH; Kou, XX; Li, CS; Meng, Z; Wang, XD; Xue, XT; Zhou, YH | 1 |
Aggarwal, P; Dadhwal, V; Mittal, S | 1 |
Chen, AM; Cheng, YM; Gao, ES; Liang, H; Luo, L; Yuan, W | 1 |
Bloigu, A; Gissler, M; Heikinheimo, O; Hemminki, E; Männistö, J; Mentula, M; Niinimäki, M | 1 |
Bouaziz, H; Guerci, P; Morel, O; Mory, S; Nelis, UM; Raft, J; Vial, F | 1 |
Baton Saint-mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
Bjørge, L; Iversen, OE | 1 |
el-Refaey, H; Henshaw, R; Hinshaw, K; Smith, N; Templeton, A | 1 |
1 review(s) available for mifepristone and Complications, Pregnancy
Article | Year |
---|---|
[Mifepristone--a controversial drug with great potential].
Topics: Abortifacient Agents, Steroidal; Contraceptives, Oral, Synthetic; Female; Genital Diseases, Female; History, 20th Century; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Neoplasms; Pregnancy; Pregnancy Complications; Receptors, Progesterone | 2001 |
10 other study(ies) available for mifepristone and Complications, Pregnancy
Article | Year |
---|---|
Up-regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy.
Topics: Animals; CD36 Antigens; Corticosterone; Fatty Acids; Female; Humans; Hydrocortisone; Hypertriglyceridemia; Lipids; Liver; Mice; Mifepristone; Pregnancy; Pregnancy Complications; Receptors, Glucocorticoid; Up-Regulation | 2022 |
Clinical application of low-dose misoprostol in the induced labor of 16 to 28 weeks pathological pregnancies (a STROBE-compliant article).
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Asian People; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Oligohydramnios; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Time Factors; Uterine Rupture | 2019 |
Combination of medical and surgical management in successful treatment of caesarean scar pregnancy: a case report series.
Topics: Abortion, Induced; Adult; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Fertility Preservation; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome; Ultrasonography, Doppler, Color; Uterine Artery Embolization; Uterine Hemorrhage; Uterus; Young Adult | 2020 |
Progesterone attenuates temporomandibular joint inflammation through inhibition of NF-κB pathway in ovariectomized rats.
Topics: Animals; Cytokines; Female; Humans; Mifepristone; NF-kappa B; Pregnancy; Pregnancy Complications; Progesterone; Rats; Rats, Sprague-Dawley; Signal Transduction; Synovial Membrane; Temporomandibular Joint; Temporomandibular Joint Disorders | 2017 |
Medical abortion in women with impaired renal function.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Kidney Diseases; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications; Severity of Illness Index | 2011 |
Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; China; Cohort Studies; Curettage; Female; Follow-Up Studies; Humans; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Risk; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult | 2011 |
Medical versus surgical termination of pregnancy in primigravid women--is the next delivery differently at risk? A population-based register study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Birth Intervals; Dilatation and Curettage; Drug Combinations; Female; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Maternal Age; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Registries; Risk Factors; Socioeconomic Factors; Young Adult | 2013 |
[Medical termination of pregnancy in a patient with severe cystic fibrosis. Possible effect of the antiglucocorticoid action of mifepristone on the respiratory disease].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cystic Fibrosis; Female; Humans; Intraoperative Complications; Mifepristone; Monitoring, Intraoperative; Pregnancy; Pregnancy Complications | 2013 |
[Inducing embryo expulsion in women with spontaneous fetal death in the first trimester. Use of mifepristone (RU-486) in a prospective, randomized, double blind study].
Topics: Abortion, Spontaneous; Biology; Demography; Developed Countries; Disease; Double-Blind Method; Endocrine System; Europe; Fetal Death; France; Hormone Antagonists; Hormones; Mifepristone; Mortality; Physiology; Population; Population Dynamics; Pregnancy Complications; Research | 1993 |
Medical management of missed abortion and anembryonic pregnancy.
Topics: Abortion, Induced; Abortion, Missed; Administration, Oral; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First | 1992 |